Focused FDA Mock Review Module
For medical devices with IFU, package labeling, digital interfaces, or promotional materials, Panabistics reviews the labeling and claims package against FDA expectations and produces a mock deficiency letter identifying likely review questions before submission.
Available Now. Expert-led, reviewer-style regulatory consulting.
Review Scope
| Area Reviewed | What We Assess |
|---|---|
| IFU | Whether instructions for use are complete, accurate, and appropriate for intended users and use environment. |
| Package labeling | Whether package labels include required content, warnings, and identifiers consistent with FDA expectations. |
| Symbols | Whether symbols are correctly applied, explained, and aligned with applicable standards and FDA requirements. |
| UDI | Whether UDI content, labeling placement, and database alignment are adequate for the submission pathway. |
| Promotional claims | Whether marketing and promotional claims are supported by submitted evidence and not overclaimed. |
| App screens | Whether software and app user interfaces present accurate, safe, and appropriately scoped information to users. |
| Cybersecurity instructions | Whether cybersecurity-related labeling is adequate, user-appropriate, and aligned with the cybersecurity package. |
| Claims vs evidence | Whether stated indications, performance claims, and limitations are traceable to supporting test and clinical evidence. |
| Substantial equivalence labeling | Whether 510(k) labeling comparisons to the predicate are credible and appropriately scoped. |
Deliverables
FDA-style questions and deficiencies focused on likely labeling and claims review concerns.
Excel-style tracker with issue, source, severity, regulatory basis, recommended fix, and owner field.
Clear readiness summary with go, conditional-go, or not-ready recommendation.
Prioritized steps to strengthen the labeling package before submission.
Support to revise documents, address gaps, and prepare stronger FDA-facing labeling evidence.
Audience
This service does not replace FDA review, labeling design, legal review of claims, advertising compliance, or the sponsor’s responsibility for submission content. It is an independent regulatory and submission-readiness review designed to identify likely FDA review concerns before submission. Panabistics does not represent FDA and does not guarantee clearance or approval.
This focused module can be commissioned independently or included as an applicable component of a broader Full eSTAR Mock Deficiency Review when the substantially complete submission package is available.
Explore the Full eSTAR Mock ReviewSelect a focused review module or explore the Full eSTAR Mock Deficiency Review for a broader submission-readiness assessment.
Request a Review
Tell us about your device, submission pathway, and labeling package. We will respond within 24 business hours.